Nicholas Draeger
Keine laufenden Positionen mehr
Karriereverlauf von Nicholas Draeger
Ehemalige bekannte Positionen von Nicholas Draeger
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Direktor/Vorstandsmitglied | - | 29.07.2019 |
Vorstandsvorsitzender | 05.03.2019 | 29.07.2019 | |
Crédit Agricole Cheuvreux SA
Crédit Agricole Cheuvreux SA Investment Banks/BrokersFinance In May 2013, Kepler Capital Markets SA completed the acquisition of Crédit Agricole Cheuvreux SA from Crédit Agricole Corporate & Investment Bank SA, a unit of Crédit Agricole SA. Kepler Capital Markets intends to combine its business with Crédit Agricole Cheuvreux under a new entity, Kepler Cheuvreux, in 2013, and will be headquartered in Paris. They will have offices in Amsterdam, Boston, Frankfurt, Geneva, London, Madrid, Milan, New York, San Francisco, Stockholm, Vienna and Zurich. | Analyst-Equity | 18.12.2001 | 18.12.2001 |
Octa Phillip Bioscience Advisory Pty Ltd.
Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Director of Investments | 11.07.2012 | - |
Private Equity Investor | 03.06.2011 | - | |
Adamant Biomedical Investments AG
Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Analyst-Equity | 01.12.2003 | - |
Ausbildung von Nicholas Draeger
University of Cambridge | Doctorate Degree |
Warwick Business School | Masters Business Admin |
University of KwaZulu-Natal | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 4 |
Schweiz | 3 |
Frankreich | 2 |
Operativ
Analyst-Equity | 2 |
Director of Investments | 1 |
Private Equity Investor | 1 |
Sektoral
Finance | 4 |
Consumer Services | 4 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Adamant Biomedical Investments AG
Adamant Biomedical Investments AG Investment ManagersFinance Adamant Biomedical Investments AG (Adamant) is the subsidiary of Bellevue Group AG (SW: BBN) in Switzerland. The firm was established in 2000 as a joint venture between Swiss Life Asset Management and three partners, formerly with the Bellevue Group (which comprises BB Biotech and BB Medtech). The firm's name derives from the Greek word for 'uncut diamond' and refers to their philosophy of uncovering hidden value. Located in Zurich, Adamant is a biomedical sector specialist. The firm manages sector-specific portfolios domiciled in Luxembourg. Their clients are institutions. | Finance |
Crédit Agricole Cheuvreux SA
Crédit Agricole Cheuvreux SA Investment Banks/BrokersFinance In May 2013, Kepler Capital Markets SA completed the acquisition of Crédit Agricole Cheuvreux SA from Crédit Agricole Corporate & Investment Bank SA, a unit of Crédit Agricole SA. Kepler Capital Markets intends to combine its business with Crédit Agricole Cheuvreux under a new entity, Kepler Cheuvreux, in 2013, and will be headquartered in Paris. They will have offices in Amsterdam, Boston, Frankfurt, Geneva, London, Madrid, Milan, New York, San Francisco, Stockholm, Vienna and Zurich. | Finance |
Octa Phillip Bioscience Advisory Pty Ltd.
Octa Phillip Bioscience Advisory Pty Ltd. Investment ManagersFinance Octa Phillip Bioscience Advisory Pty Ltd (Octa Phillip Bioscience) is a private equity firm founded in 2003. The firm is headquartered in Sydney, Australia. | Finance |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Health Technology |
- Börse
- Insiders
- Nicholas Draeger
- Erfahrung